Search

Syed Taha Iqbal

Examiner (ID: 5838, Phone: (571)270-5857 , Office: P/1736 )

Most Active Art Unit
1736
Art Unit(s)
1793, 1736
Total Applications
941
Issued Applications
713
Pending Applications
67
Abandoned Applications
178

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14132699 [patent_doc_number] => 20190100739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-04 [patent_title] => METHODS FOR THE MANUFACTURE OF PROTEOLYTICALLY PROCESSED POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 16/105120 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105120 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/105120
Methods for the manufacture of proteolytically processed polypeptides Aug 19, 2018 Issued
Array ( [id] => 16771103 [patent_doc_number] => 10982198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-20 [patent_title] => Compositions and methods relating to a mutant [patent_app_type] => utility [patent_app_number] => 16/104938 [patent_app_country] => US [patent_app_date] => 2018-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 63 [patent_no_of_words] => 67070 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104938 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/104938
Compositions and methods relating to a mutant Aug 18, 2018 Issued
Array ( [id] => 16451074 [patent_doc_number] => 20200360500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/638846 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638846 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/638846
PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS Aug 12, 2018 Abandoned
Array ( [id] => 16459530 [patent_doc_number] => 10842858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Compositions and methods of enhancing immune responses to [patent_app_type] => utility [patent_app_number] => 16/028599 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6672 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028599 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028599
Compositions and methods of enhancing immune responses to Jul 5, 2018 Issued
Array ( [id] => 17489300 [patent_doc_number] => 11278581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Use of vaginal [patent_app_type] => utility [patent_app_number] => 16/627248 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11134 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627248 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627248
Use of vaginal Jul 4, 2018 Issued
Array ( [id] => 15990473 [patent_doc_number] => 20200171107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS [patent_app_type] => utility [patent_app_number] => 16/627118 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627118 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627118
HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS Jul 4, 2018 Abandoned
Array ( [id] => 16296314 [patent_doc_number] => 20200282037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => BACTERIAL VACCINE [patent_app_type] => utility [patent_app_number] => 16/622900 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -108 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622900 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622900
BACTERIAL VACCINE Jun 14, 2018 Abandoned
Array ( [id] => 16009135 [patent_doc_number] => 20200179410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/620376 [patent_app_country] => US [patent_app_date] => 2018-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620376 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/620376
Vitamin D compounds and methods of using the same Jun 7, 2018 Issued
Array ( [id] => 16634336 [patent_doc_number] => 10912823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-09 [patent_title] => Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin [patent_app_type] => utility [patent_app_number] => 15/992627 [patent_app_country] => US [patent_app_date] => 2018-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992627 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/992627
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin May 29, 2018 Issued
Array ( [id] => 13593339 [patent_doc_number] => 20180348218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => SEROLOGY ASSAY FOR RECENT MALARIA INFECTION [patent_app_type] => utility [patent_app_number] => 15/991355 [patent_app_country] => US [patent_app_date] => 2018-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991355 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/991355
SEROLOGY ASSAY FOR RECENT MALARIA INFECTION May 28, 2018 Abandoned
Array ( [id] => 13440833 [patent_doc_number] => 20180271959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/989742 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989742 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989742
SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS May 24, 2018 Abandoned
Array ( [id] => 13563849 [patent_doc_number] => 20180333472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => TREATMENT OF PLANTAR FASCIITIS [patent_app_type] => utility [patent_app_number] => 15/978931 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3715 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978931 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978931
TREATMENT OF PLANTAR FASCIITIS May 13, 2018 Abandoned
Array ( [id] => 13383613 [patent_doc_number] => 20180243348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS [patent_app_type] => utility [patent_app_number] => 15/964285 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964285 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/964285
Human-derived bacteria that induce proliferation or accumulation of regulatory T cells Apr 26, 2018 Issued
Array ( [id] => 16762606 [patent_doc_number] => 20210108187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => BOTULINUM NEUROTOXINS PRODUCTION METHODS [patent_app_type] => utility [patent_app_number] => 16/608360 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608360 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608360
BOTULINUM NEUROTOXINS PRODUCTION METHODS Apr 26, 2018 Abandoned
Array ( [id] => 13383735 [patent_doc_number] => 20180243409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => SYNTHETIC CONJUGATE OF CpG DNA AND T-HELP/CTL PEPTIDE [patent_app_type] => utility [patent_app_number] => 15/963173 [patent_app_country] => US [patent_app_date] => 2018-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963173 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/963173
Synthetic conjugate of CpG DNA and T-help/CTL peptide Apr 25, 2018 Issued
Array ( [id] => 16491202 [patent_doc_number] => 10857220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Staphylococcal coagulase antigens and methods of their use [patent_app_type] => utility [patent_app_number] => 15/962115 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 44662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962115 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/962115
Staphylococcal coagulase antigens and methods of their use Apr 24, 2018 Issued
Array ( [id] => 16259986 [patent_doc_number] => 10751395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Method of treating depression [patent_app_type] => utility [patent_app_number] => 15/957494 [patent_app_country] => US [patent_app_date] => 2018-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957494 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/957494
Method of treating depression Apr 18, 2018 Issued
Array ( [id] => 15130083 [patent_doc_number] => 10478478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Treatment of Raynaud's phenomenon using botulinum toxin type B [patent_app_type] => utility [patent_app_number] => 15/941089 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3071 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941089 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/941089
Treatment of Raynaud's phenomenon using botulinum toxin type B Mar 29, 2018 Issued
Array ( [id] => 15493251 [patent_doc_number] => 20200046814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => BOTULINUM NEUROTOXINS FOR USE IN THERAPY [patent_app_type] => utility [patent_app_number] => 16/496011 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496011 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496011
Botulinum neurotoxins for use in therapy Mar 21, 2018 Issued
Array ( [id] => 13462321 [patent_doc_number] => 20180282703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 15/925633 [patent_app_country] => US [patent_app_date] => 2018-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925633 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/925633
Bacteriophage and antibacterial composition comprising the same Mar 18, 2018 Issued
Menu